We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
-1.97%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
AUM
$2.67B
AUM Growth
+$646M
Cap. Flow
+$642M
Cap. Flow %
24.04%
Top 10 Hldgs %
90.2%
Holding
108
New
16
Increased
41
Reduced
27
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 5.68%
2 Energy 1.02%
3 Real Estate 0.4%
4 Industrials 0.14%
5 Consumer Discretionary 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCY
51
DELISTED
Simplify US Small Cap PLUS Income ETF
SCY
$1.86M 0.07%
+95,000
New +$2.06M
SNDX icon
52
Syndax Pharmaceuticals
SNDX
$1.99B
$1.82M 0.07%
147,785
+144
+0.1% +$2.03K
TFX icon
53
Teleflex
TFX
$5.94B
$1.77M 0.07%
12,826
+84
+0.7% +$13.6K
REGN icon
54
Regeneron Pharmaceuticals
REGN
$70.7B
$1.75M 0.07%
2,758
-3,500
-56% -$2.41M
RVTY icon
55
Revvity
RVTY
$11.9B
$1.69M 0.06%
16,003
+83
+0.5% +$9.57K
INSM icon
56
Insmed
INSM
$23.4B
$1.57M 0.06%
20,630
+110
+0.5% +$8.41K
DCTH icon
57
Delcath Systems
DCTH
$428M
$1.49M 0.06%
117,000
+100,000
+588% +$1.42M
TCRX icon
58
TScan Therapeutics
TCRX
$58.6M
$1.44M 0.05%
1,046,916
ABT icon
59
Abbott
ABT
$176B
$1.44M 0.05%
10,858
-11,221
-51% -$1.43M
WUSA
60
DELISTED
Simplify Wolfe US Equity 150/50 ETF
WUSA
$1.36M 0.05%
57,200
-2,600
-4% -$66.3K
DXCM icon
61
DexCom
DXCM
$29.5B
$1.28M 0.05%
18,809
-86,596
-82% -$7.07M
PMT
62
PennyMac Mortgage Investment
PMT
$859M
$1.26M 0.05%
86,100
+28,500
+49% +$390K
BNTC icon
63
Benitec Biopharma
BNTC
$423M
$998K 0.04%
76,735
+398
+0.5% +$4.82K
ARGX icon
64
argenx
ARGX
$53.7B
$958K 0.04%
1,619
+8
+0.5% +$5.05K
CIM
65
Chimera Investment
CIM
$1.07B
$907K 0.03%
70,700
+45,000
+175% +$632K
ZVRA icon
66
Zevra Therapeutics
ZVRA
$739M
$899K 0.03%
120,000
SPQ
67
DELISTED
Simplify US Equity PLUS QIS ETF
SPQ
$795K 0.03%
32,131
-1,461
-4% -$39.4K
NXTI icon
68
Simplify Next Intangible Core Index ETF
NXTI
$40.2M
$714K 0.03%
25,825
-1,174
-4% -$34K
EW icon
69
Edwards Lifesciences
EW
$49.2B
$710K 0.03%
9,799
-70,959
-88% -$5.08M
LGND icon
70
Ligand Pharmaceuticals
LGND
$6.04B
$696K 0.03%
+6,616
New +$748K
MIST icon
71
Milestone Pharmaceuticals
MIST
$147M
$680K 0.03%
+850,000
New +$1.69M
ESTA icon
72
Establishment Labs
ESTA
$2.72B
$662K 0.02%
16,222
-48,078
-75% -$1.79M
NXTV
73
DELISTED
Simplify Next Intangible Value Index ETF
NXTV
$659K 0.02%
25,825
-1,174
-4% -$30.5K
ARR
74
Armour Residential REIT
ARR
$2.05B
$641K 0.02%
37,500
+10,000
+36% +$186K
CVS icon
75
CVS Health
CVS
$138B
$617K 0.02%
9,105
-9
-0.1% -$539

Similar funds

Simplify Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, Simplify Asset Management held 108 positions worth $2.67B, up 32% from $2.02B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Simplify Asset Management deployed $642M of net new capital in Q1 2025, opening 16 new positions and adding to 41 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 872,087 shares worth $488M.

By sector, the portfolio is most concentrated in Healthcare at 5.7% of assets, down from 7.7% a quarter earlier, followed by Energy and Real Estate.

On the sell side, the largest reduction was DexCom, an estimated $7.07M trimmed.

  • Simplify Asset Management's largest Q1 2025 buy was State Street SPDR S&P 500 ETF Trust: 872,087 shares worth $488M.
  • Simplify Asset Management added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $128M increase.
  • Simplify Asset Management's biggest Q1 2025 reduction was DexCom, cutting an estimated $7.07M.
  • Simplify Asset Management fully exited Simplify Stable Income ETF in Q1 2025, selling an estimated $109M.
  • Simplify Asset Management's ten largest holdings make up 90% of its $2.67B portfolio in Q1 2025.
  • Simplify Asset Management opened 16 new positions and closed 14 in Q1 2025.
  • Simplify Asset Management's portfolio value rose 32% quarter-over-quarter to $2.67B.

Based on Simplify Asset Management's 13F filing for Q1 2025, filed 13 May 2025.